Johnson & Johnson bets $1 billion on hard-to-treat cancer

Johnson & Johnson (JNJ) is one of the biggest names in health care, and lately, its stock has been living up to the hype. Shares have climbed back toward record territory, while much of the market has been affected by a sharp sell-off in technology stocks. Now, the company is pumping fresh cash ...

Johnson & Johnson (JNJ) is one of the biggest names in health care, and lately, its stock has been living up to the hype. Shares have climbed back toward record territory, while much of the market has been affected by a sharp sell-off in technology stocks. Now, the company is pumping fresh cash ...

Johnson & Johnson (JNJ) is one of the biggest names in health care, and lately, its stock has been living up to the hype. Shares have climbed back toward record territory, while much of the market has been affected by a sharp sell-off in technology stocks. Now, the company is pumping fresh cash ...